Quick Answer
Verastem, Inc. reported Cash and Equivalents of $204.99 million for fiscal year 2025.
Verastem, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $204.99M | +130.8% |
| 2024 | $88.82M | +14.0% |
| 2023 | $77.91M | +4.0% |
| 2022 | $74.93M | +252.6% |
| 2021 | $21.25M | -68.6% |
| 2020 | $67.78M | +55.8% |
| 2019 | $43.51M | -66.5% |
| 2018 | $129.87M | +58.0% |
| 2017 | $82.18M | +154.0% |
| 2016 | $32.35M | +30.1% |
| 2015 | $24.87M | -26.6% |
| 2014 | $33.90M | +79.5% |
| 2013 | $18.89M | +87.1% |
| 2012 | $10.10M | -70.2% |
| 2011 | $33.90M | +845.9% |
| 2010 | $3.58M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $137.71M | +21.7% | -16.2% |
| June 30, 2025 | $164.32M | +97.1% | +39.8% |
| March 31, 2025 | $117.57M | +44.6% | +32.4% |
| December 31, 2024 | $88.82M | +14.0% | -21.5% |
| September 30, 2024 | $113.17M | +19.1% | +35.7% |
| June 30, 2024 | $83.37M | -54.5% | +2.5% |
| March 31, 2024 | $81.32M | -16.4% | +4.4% |
| December 31, 2023 | $77.91M | +4.0% | -18.0% |
- Verastem, Inc. showed an increase of +130.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2025 period, Verastem, Inc.’s cash and equivalents has grown by 5619.6% (from $3.58 million to $204.99 million).
- The most recent figure is from Verastem, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: